Prospective Economic Evaluation Ancillary to a Trial of Higher versus Lower Hemoglobin Transfusion Thresholds for Preterm Infants
Neonatology · 29.06.2026 · 1-12
DOI: 10.1159/000551672 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neonatology, online erschienen am 29.06.2026. Verfasst von John A F Zupancic und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA, jzupanci@bidmc.harvard.edu. Die Arbeit nennt 15 Literaturangaben. Gefördert von: NHLBI NIH HHS.
Themen: Neonatologie
Abstract (Originalsprache)
Introduction
The Higher or Lower Hemoglobin Transfusion Thresholds for Preterm Infants randomized trial compared higher versus lower hemoglobin transfusion thresholds in extremely low birth weight infants. This publication compares the economic implications of the two strategies.
Methods
We undertook a prospectively planned economic evaluation, using patient-level data from the parent clinical trial. We report costs in 2020 US dollars, from health sector and modified societal perspectives, with a time horizon through the end of clinical follow-up. We derived costs from hospital finance systems, Medicaid fee schedules, family questionnaires, and efficacy from trial data.
Results
Of the 1,824 patients enrolled at 19 centers in the trial, data were available for 1,305 for analysis from a health sector perspective and 752 for analysis from a societal perspective. The mean cost from the health sector perspective was USD 331,186 per patient in the higher hemoglobin transfusion threshold group and USD 351,579 in the lower hemoglobin transfusion threshold group; the difference was not statistically significant after adjustment for study site and birth weight stratum (p = 0.085). The difference in mean costs from the societal perspective was also not statistically significant (p = 0.094). The incremental cost-effectiveness ratios for adoption of a lower transfusion threshold from health sector and societal perspectives were USD 6,797,666 and USD 5,596,666 per additional survivor without neurodevelopmental impairment, respectively. There was substantial uncertainty in these cost-effectiveness estimates.
Discussion
Similarly to prior results for clinical efficacy, choosing between a lower or higher hemoglobin transfusion threshold for extremely preterm infants has no significant economic advantage.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neonatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA, jzupanci@bidmc.harvard.edu.
- Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA, jzupanci@bidmc.harvard.edu.
- Department of Neonatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
- Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
- Division of Neonatology, University of Florida, Gainesville, Florida, USA.
- Department of Pediatrics, Oregon Health & Science University, Portland, Oregon, USA.
Förderung
- NHLBI NIH HHS
Zitieren
APA
Zupancic, J. A. F., King, B. C., Mowitz, M., Mao, W., Dukhovny, D., Schmidt, B., Tan, S., Chaudhary, A. S., Crawford, M. M., Bell, E. F., O'Donnell Auman, J., Walsh, M. C., Higgins, R. D., Das, A., & Kirpalani, H. (2026). Prospective Economic Evaluation Ancillary to a Trial of Higher versus Lower Hemoglobin Transfusion Thresholds for Preterm Infants. Neonatology, 1-12. https://doi.org/10.1159/000551672
Vancouver
Zupancic JAF, King BC, Mowitz M, Mao W, Dukhovny D, Schmidt B, et al. Prospective Economic Evaluation Ancillary to a Trial of Higher versus Lower Hemoglobin Transfusion Thresholds for Preterm Infants. Neonatology. 2026:1-12. doi:10.1159/000551672
BibTeX
@article{Zupancic2026,
author = {Zupancic, John A F and King, Brian C and Mowitz, Meredith and Mao, Wenyang and Dukhovny, Dmitry and Schmidt, Barbara and Tan, Sylvia and Chaudhary, Aasma S and Crawford, Margaret M and Bell, Edward F and O'Donnell Auman, Jeanette and Walsh, Michele C and Higgins, Rosemary D and Das, Abhik and Kirpalani, Haresh},
title = {Prospective Economic Evaluation Ancillary to a Trial of Higher versus Lower Hemoglobin Transfusion Thresholds for Preterm Infants},
journal = {Neonatology},
year = {2026},
pages = {1--12},
doi = {10.1159/000551672}
}
EUVIMED